Gene · 6103
Papers1,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The impact of modifier genes on cone-rod dystrophy heterogeneity: An explorative familial pilot study and a hypothesis on neurotransmission impairment. | PLoS One | 2022 | 36490268 | PubTator, text mining | PubMed |
| Potential therapeutic strategies for photoreceptor degeneration: the path to restore vision. | J Transl Med | 2022 | 36476500 | PubTator, text mining | PubMed |
| Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities. | J Nanobiotechnology | 2022 | 36463195 | PubTator, text mining | PubMed |
| Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy. | Sci Rep | 2022 | 36460718 | PubTator, text mining | PubMed |
| Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS. | Elife | 2022 | 36458814 | PubTator, text mining | PubMed |
| Impaired glutamylation of RPGRORF15 underlies the cone-dominated phenotype associated with truncating distal ORF15 variants. | Proc Natl Acad Sci U S A | 2022 | 36445968 | PubTator, text mining | PubMed |
| The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease. | Cardiovasc Diabetol | 2022 | 36403025 | PubTator, text mining | PubMed |
| Multi-omics to predict changes during cold pressor test. | BMC Genomics | 2022 | 36402977 | PubTator, text mining | PubMed |
| Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC). | Cancer Cell Int | 2022 | 36376957 | PubTator, text mining | PubMed |
| Tocotrienol-Rich Fraction and Levodopa Regulate Proteins Involved in Parkinson's Disease-Associated Pathways in Differentiated Neuroblastoma Cells: Insights from Quantitative Proteomic Analysis. | Nutrients | 2022 | 36364894 | PubTator, text mining | PubMed |
| A 100 KS/s 8-10-Bit Resolution-Reconfigurable SAR ADC for Biosensor Applications. | Micromachines (Basel) | 2022 | 36363934 | PubTator, text mining | PubMed |
| Bioengineering Human Pluripotent Stem Cell-Derived Retinal Organoids and Optic Vesicle-Containing Brain Organoids for Ocular Diseases. | Cells | 2022 | 36359825 | PubTator, text mining | PubMed |
| Five years' experience of the clinical exome sequencing in a Spanish single center. | Sci Rep | 2022 | 36357507 | PubTator, text mining | PubMed |
| In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications. | Biomaterials | 2022 | 36334354 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| The inner junction protein CFAP20 functions in motile and non-motile cilia and is critical for vision. | Nat Commun | 2022 | 36329026 | PubTator, text mining | PubMed |
| Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities. | Asian J Pharm Sci | 2022 | 36320315 | PubTator, text mining | PubMed |
| Ocular Gene Therapy: A Literature Review With Focus on Current Clinical Trials. | Cureus | 2022 | 36312652 | PubTator, text mining | PubMed |
| The Modifying Effect of Obesity on the Association of Matrix Metalloproteinase Gene Polymorphisms with Breast Cancer Risk. | Biomedicines | 2022 | 36289879 | PubTator, text mining | PubMed |
| Nasal Nitric Oxide Levels: Improving the Diagnosis of Primary Ciliary Dyskinesia in Puerto Rico. | Adv Respir Med | 2022 | 36285978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6103/papers?page=19